Logotype for Moberg Pharma

Moberg Pharma (MOB) investor relations material

Moberg Pharma Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Moberg Pharma
Q3 2025 earnings summary11 Nov, 2025

Executive summary

  • Achieved strong market leadership for TerclaraⓇ in Sweden (47% value share) and Norway (37% value share) during Q3 2025, with continued expansion into Europe via a new license agreement with Karo Healthcare covering 19 markets.

  • MOB-015/TerclaraⓇ to be launched under the Lamisil® brand, leveraging Karo Healthcare's distribution network for broad European coverage.

  • Product recognized for launch excellence, including a nomination for "Launch of the Year" in Norway.

Financial highlights

  • Net revenue for Jan–Sep 2025 was SEK 11.5 million, up from SEK 8.8 million year-over-year; Q3 revenue was SEK 4.0 million (Q3 2024: SEK 3.9 million, which included a SEK 1.7 million milestone payment).

  • EBITDA for Jan–Sep 2025 was SEK -18.7 million (2024: -15.7 million); Q3 EBITDA was SEK -5.6 million (2024: -3.0 million).

  • Operating profit (EBIT) for Jan–Sep 2025 was SEK -19.9 million (2024: -16.7 million); Q3 EBIT was SEK -6.0 million (2024: -3.3 million).

  • Profit for Jan–Sep 2025 was SEK -14.5 million (2024: -11.8 million); Q3 profit was SEK -4.3 million (2024: -1.3 million).

  • Cash and cash equivalents at period end were SEK 236.2 million (2024: SEK 309.0 million).

Outlook and guidance

  • Focus remains on launching MOB-015 in 11 additional approved European countries, with further expansion planned as regulatory approvals for the Lamisil® brand are obtained.

  • Priority given to markets with existing commercial partners and high commercial potential.

  • U.S. launch timeline extended pending additional clinical data; near-term focus is on Europe.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Moberg Pharma earnings date

Logotype for Moberg Pharma
Q4 202511 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Moberg Pharma earnings date

Logotype for Moberg Pharma
Q4 202511 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Moberg Pharma AB develops, manufactures and markets OTC products in the areas of footcare and oral healthcare. The company own the rights to a patented platform technology, which means that they can tailor each product exactly to the needs of each customer. The products are primarily sold through intermediaries and are developed in close collaboration with leading retailers, who sell them on their home markets. Moberg Pharma AB market some of their products directly under their own brands, or via the company's own sales force on a limited number of selected markets.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage